Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Hess

Showing results (41-50 of 94) with videos related to

Pageof 10
Sort By:
Journal for Immunotherapy of Cancer|December 20, 2017
Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trialsRoman Groisberg, David S Hong, Amini Behrang, et al.
Investigational New Drugs|August 5, 2004
Phase I/pharmacokinetic study of CCI-779 in patients with recurrent malignant glioma on enzyme-inducing antiepileptic drugsSusan M Chang, John Kuhn, Patrick Wen, et al.
Academic Radiology|September 20, 2021
Prospective Comparison of Synthesized Mammography with DBT and Full-Field Digital Mammography with DBT Uncovers Recall Disagreements That may Impact Cancer DetectionMonica L Huang, Kenneth Hess, Junsheng Ma, et al.
The Oncologist|December 8, 2020
High-Flow Nasal Cannula Therapy for Exertional Dyspnea in Patients with Cancer: A Pilot Randomized Clinical TrialDavid Hui, Donald A Mahler, Liliana Larsson, et al.
Neuro-Oncology|March 28, 2002
A phase II trial of thymidine and carboplatin for recurrent malignant glioma: a North American Brain Tumor Consortium StudyH Ian Robins, Susan M Chang, Michael D Prados, et al.
Endocrine-Related Cancer|April 23, 2015
Phase I study of the anti-IGF1R antibody cixutumumab with everolimus and octreotide in advanced well-differentiated neuroendocrine tumorsArvind Dasari, Alexandria Phan, Sanjay Gupta, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 21, 2012
Insulin-like growth factor-binding protein 2-driven glioma progression is prevented by blocking a clinically significant integrin, integrin-linked kinase, and NF-κB networkKristen M Holmes, Matti Annala, Corrine Y X Chua, et al.
Breast Cancer Research and Treatment|February 26, 2009
Decreased TGFbeta signaling and increased COX2 expression in high risk women with increased mammographic breast densityWei Tse Yang, Michael T Lewis, Kenneth Hess, et al.
Investigational New Drugs|January 29, 2010
A phase II study of isoflavones, erlotinib, and gemcitabine in advanced pancreatic cancerBassel Fuad El-Rayes, Philip A Philip, Fazlul H Sarkar, et al.
Cancer|April 10, 2004
Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: a North American Brain Tumor Consortium TrialSusan M Chang, Michael D Prados, W K Alfred Yung, et al.
Pageof 10

Showing results (41-50 of 94) with videos related to

Sort By:
Pageof 10
Journal for Immunotherapy of Cancer|December 20, 2017
Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trialsRoman Groisberg, David S Hong, Amini Behrang, et al.
Investigational New Drugs|August 5, 2004
Phase I/pharmacokinetic study of CCI-779 in patients with recurrent malignant glioma on enzyme-inducing antiepileptic drugsSusan M Chang, John Kuhn, Patrick Wen, et al.
Academic Radiology|September 20, 2021
Prospective Comparison of Synthesized Mammography with DBT and Full-Field Digital Mammography with DBT Uncovers Recall Disagreements That may Impact Cancer DetectionMonica L Huang, Kenneth Hess, Junsheng Ma, et al.
The Oncologist|December 8, 2020
High-Flow Nasal Cannula Therapy for Exertional Dyspnea in Patients with Cancer: A Pilot Randomized Clinical TrialDavid Hui, Donald A Mahler, Liliana Larsson, et al.
Neuro-Oncology|March 28, 2002
A phase II trial of thymidine and carboplatin for recurrent malignant glioma: a North American Brain Tumor Consortium StudyH Ian Robins, Susan M Chang, Michael D Prados, et al.
Endocrine-Related Cancer|April 23, 2015
Phase I study of the anti-IGF1R antibody cixutumumab with everolimus and octreotide in advanced well-differentiated neuroendocrine tumorsArvind Dasari, Alexandria Phan, Sanjay Gupta, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 21, 2012
Insulin-like growth factor-binding protein 2-driven glioma progression is prevented by blocking a clinically significant integrin, integrin-linked kinase, and NF-κB networkKristen M Holmes, Matti Annala, Corrine Y X Chua, et al.
Breast Cancer Research and Treatment|February 26, 2009
Decreased TGFbeta signaling and increased COX2 expression in high risk women with increased mammographic breast densityWei Tse Yang, Michael T Lewis, Kenneth Hess, et al.
Investigational New Drugs|January 29, 2010
A phase II study of isoflavones, erlotinib, and gemcitabine in advanced pancreatic cancerBassel Fuad El-Rayes, Philip A Philip, Fazlul H Sarkar, et al.
Cancer|April 10, 2004
Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: a North American Brain Tumor Consortium TrialSusan M Chang, Michael D Prados, W K Alfred Yung, et al.
Pageof 10